Session

PP 05 IBD (Posters)

REAL-LIFE EXPERIENCE OF THE EFFICACY, SAFETY AND PHARMACOKINETIC DATA OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN INACTIVE INFLAMMATORY BOWEL DISEASE PATIENTS. RESULTS FROM THE ENEIDA REGISTRY
REAL-LIFE EXPERIENCE OF THE EFFICACY, SAFETY AND PHARMACOKINETIC DATA OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN INACTIVE INFLAMMATORY BOWEL DISEASE PATIENTS. RESULTS FROM THE ENEIDA REGISTRY

THE DISAPPEARANCE OF CELL DEATH BRAKES: A NEW MOLECULAR DEFECT IN INFLAMMATORY BOWEL DISEASE (IBD)
THE DISAPPEARANCE OF CELL DEATH BRAKES: A NEW MOLECULAR DEFECT IN INFLAMMATORY BOWEL DISEASE (IBD)

EARLY REAL WORLD EXPERIENCE OF FILGOTINIB FOR TREATMENT OF MODERATE-SEVERE ULCERATIVE COLITIS
EARLY REAL WORLD EXPERIENCE OF FILGOTINIB FOR TREATMENT OF MODERATE-SEVERE ULCERATIVE COLITIS

CROHN'S DISEASE LIKE POUCH INFLAMMATION (CDLPI), IN ILEAL POUCH–ANAL ANASTOMOSIS (IPAA) FOR ULCERATIVE COLITIS (UC), IN A LATIN AMERICAN IBD REFERENCE CENTER
CROHN'S DISEASE LIKE POUCH INFLAMMATION (CDLPI), IN ILEAL POUCH–ANAL ANASTOMOSIS (IPAA) FOR ULCERATIVE COLITIS (UC), IN A LATIN AMERICAN IBD REFERENCE CENTER

ASSOCIATION OF MICRONUTRIENTS AND SERUM IMMUNOPROTEINS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE - A PRELIMINARY STUDY
ASSOCIATION OF MICRONUTRIENTS AND SERUM IMMUNOPROTEINS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE - A PRELIMINARY STUDY

THE CAUDOVIRALES CLASS OF VIRUSES IS ASSOCIATED WITH DENDRITIC CELL IMPAIRMENT IN CD PATIENTS​​​​
THE CAUDOVIRALES CLASS OF VIRUSES IS ASSOCIATED WITH DENDRITIC CELL IMPAIRMENT IN CD PATIENTS​​​​

EFFICACY AND SAFETY OF GRANULOCYTOAPHERESIS IN THE TREATMENT OF STEROID-DEPENDENT AND STEROID-REFRACTORY INFLAMMATORY BOWEL DISEASE
EFFICACY AND SAFETY OF GRANULOCYTOAPHERESIS IN THE TREATMENT OF STEROID-DEPENDENT AND STEROID-REFRACTORY INFLAMMATORY BOWEL DISEASE

SARCOPENIA AND IBD: MOLECULAR AND MICROBIAL PATHWAYS AND POTENTIAL PHARMACOLOGICAL MODULATORS IN EXPERIMENTAL MODELS OF CHRONIC INFLAMMATORY BOWEL DISEASE
SARCOPENIA AND IBD: MOLECULAR AND MICROBIAL PATHWAYS AND POTENTIAL PHARMACOLOGICAL MODULATORS IN EXPERIMENTAL MODELS OF CHRONIC INFLAMMATORY BOWEL DISEASE

THE SOLUTE TRANSPORTER OCTN1/SLC22A4 AFFECTS DISEASE SEVERITY AND RESPONSE TO INFLIXIMAB IN EXPERIMENTAL COLITIS: ROLE OF GUT MICROBIOTA AND IMMUNE MODULATION
THE SOLUTE TRANSPORTER OCTN1/SLC22A4 AFFECTS DISEASE SEVERITY AND RESPONSE TO INFLIXIMAB IN EXPERIMENTAL COLITIS: ROLE OF GUT MICROBIOTA AND IMMUNE MODULATION

UTILITY OF VEDOLIZUMAB CLINICAL DECISION SUPPORT TOOL IN PREDICTION OF BIO-NAIVE CROHN'S DISEASE PATIENTS OUTCOMES TREATED WITH ADALIMUMAB OR USTEKINUMAB
UTILITY OF VEDOLIZUMAB CLINICAL DECISION SUPPORT TOOL IN PREDICTION OF BIO-NAIVE CROHN'S DISEASE PATIENTS OUTCOMES TREATED WITH ADALIMUMAB OR USTEKINUMAB

INCIDENCE AND DISEASE COURSE OF POUCHITIS IN PATIENTS WITH ULCERATIVE COLITIS AND AN ILEAL POUCH-ANAL ANASTOMOSIS (IPAA)– A DANISH POPULATION-BASED COHORT STUDY
INCIDENCE AND DISEASE COURSE OF POUCHITIS IN PATIENTS WITH ULCERATIVE COLITIS AND AN ILEAL POUCH-ANAL ANASTOMOSIS (IPAA)– A DANISH POPULATION-BASED COHORT STUDY

METABOLOMIC BIOMARKERS OF INFLAMMATORY BOWEL DISEASE AND ITS DAMP HEAT SYNDROME IN COMPARING WITH FUNCTIONAL DIARRHEA OF CHINESE PATIENTS AND HEALTHY CONTROLS--- PRELIMINARY FINDINGS
METABOLOMIC BIOMARKERS OF INFLAMMATORY BOWEL DISEASE AND ITS DAMP HEAT SYNDROME IN COMPARING WITH FUNCTIONAL DIARRHEA OF CHINESE PATIENTS AND HEALTHY CONTROLS--- PRELIMINARY FINDINGS

THE POTENTIAL OVERLAP BETWEEN CANNABINOID AND NOCICEPTIN SIGNALING AND ITS ROLE IN INTESTINAL INFLAMMATION IN A MOUSE MODEL AND HUMAN SAMPLES
THE POTENTIAL OVERLAP BETWEEN CANNABINOID AND NOCICEPTIN SIGNALING AND ITS ROLE IN INTESTINAL INFLAMMATION IN A MOUSE MODEL AND HUMAN SAMPLES

THE TREATMENT AND TREATMENT OUTCOMES OF POUCHITIS IN PATIENTS WITH ULCERATIVE COLITIS FOLLOWING IPAA – A DANISH POPULATION-BASED COHORT STUDY
THE TREATMENT AND TREATMENT OUTCOMES OF POUCHITIS IN PATIENTS WITH ULCERATIVE COLITIS FOLLOWING IPAA – A DANISH POPULATION-BASED COHORT STUDY

TELEMEDICINE IN THE MANAGEMENT OF IBD PATIENTS: A SAFE AND FEASIBILE APPROACH WITH DEDICATED TOOLS
TELEMEDICINE IN THE MANAGEMENT OF IBD PATIENTS: A SAFE AND FEASIBILE APPROACH WITH DEDICATED TOOLS

COMMUNICATION GAP BETWEEN PATIENTS AND HEALTH CARE PROFESSIONALS ON BOWEL URGENCY WITH FOCUS ON CROHN'S DISEASE: RESULTS FROM THE COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY
COMMUNICATION GAP BETWEEN PATIENTS AND HEALTH CARE PROFESSIONALS ON BOWEL URGENCY WITH FOCUS ON CROHN'S DISEASE: RESULTS FROM THE COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY

RELATIVE ASSOCIATION OF BOWEL URGENCY CLINICALLY MEANINGFUL IMPROVEMENT AND BOWEL URGENCY REMISSION VS STOOL FREQUENCY REMISSION AND RECTAL BLEEDING REMISSION WITH IMPROVEMENT IN WPAI SCORES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITI
RELATIVE ASSOCIATION OF BOWEL URGENCY CLINICALLY MEANINGFUL IMPROVEMENT AND BOWEL URGENCY REMISSION VS STOOL FREQUENCY REMISSION AND RECTAL BLEEDING REMISSION WITH IMPROVEMENT IN WPAI SCORES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITI

RELATIVE ASSOCIATION OF BOWEL URGENCY CLINICALLY MEANINGFUL IMPROVEMENT OR BOWEL URGENCY REMISSION VS STOOL FREQUENCY REMISSION AND RECTAL BLEEDING REMISSION WITH IMPROVEMENT IN IBDQ SCORES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
RELATIVE ASSOCIATION OF BOWEL URGENCY CLINICALLY MEANINGFUL IMPROVEMENT OR BOWEL URGENCY REMISSION VS STOOL FREQUENCY REMISSION AND RECTAL BLEEDING REMISSION WITH IMPROVEMENT IN IBDQ SCORES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

​RELATIONSHIP BETWEEN DIETARY PATTERNS AND MENTAL HEALTH IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
​RELATIONSHIP BETWEEN DIETARY PATTERNS AND MENTAL HEALTH IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

AN AUSTRALIAN STUDY OF EXCLUSIVE ENTERAL NUTRITION FOR MANAGEMENT OF ACTIVE SEVERE INFLAMMATORY BOWEL DISEASE FOCUSING ON EFFICACY AND PATIENT REPORTED PERSPECTIVE
AN AUSTRALIAN STUDY OF EXCLUSIVE ENTERAL NUTRITION FOR MANAGEMENT OF ACTIVE SEVERE INFLAMMATORY BOWEL DISEASE FOCUSING ON EFFICACY AND PATIENT REPORTED PERSPECTIVE

Item 501 - 520 / 826
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
26
27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42